Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether escitalopram is safe, well tolerated, and
effective in the treatment of HIV-infected patients with generalized anxiety disorder.